Mechanism of action of the group A streptococcal C5a inactivator.
- 1 December 1985
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 82 (23) , 8144-8148
- https://doi.org/10.1073/pnas.82.23.8144
Abstract
Virulent group A streptococci have been found to express a cell-surface factor that has the capability of inactivating complement-derived chemotactic factors. To determine the mechanism of action of this factor, we examined the interaction of purified inactivator with pure C5a chemotaxin. Ligand-receptor binding studies demonstrated that streptococcal chemotactic factor inactivator (SCFI)-treated C5a expressed a greatly reduced ability to bind to receptors of polymorphonuclear leukocytes as compared with native C5a. The inactivation of C5a occurred by a nonstoichiometric and temperature-dependent process. NaDodSO4/PAGE analysis indicated that SCFI mediated a small decrease in the molecular weight of C5adesArg, and sequencing of the carboxyl terminus of inactivated C5a demonstrated that a six-residue peptide was lost. The release of discrete peptide fragments from denatured bovine serum albumin upon prolonged incubation with SCFI was indicative of endoprotease activity. Although denatured bovine serum albumin was inefficiently cleaved, native bovine serum albumin and other native proteins were highly resistant to SCFI proteolysis; this indicated that activity was specific in nature.This publication has 25 references indexed in Scilit:
- Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages.The Journal of Experimental Medicine, 1982
- A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gelsAnalytical Biochemistry, 1980
- Human C5a and C5a analogs as probes of the neutrophil C5a receptorMolecular Immunology, 1980
- A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the hypaque-ficoll techniqueJournal of Immunological Methods, 1978
- Anaphylatoxins: C3a and C5aPublished by Elsevier ,1978
- Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.Journal of Clinical Investigation, 1975
- Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors.Journal of Clinical Investigation, 1974
- BIOLOGICAL ACTIVITY OF COMPLEMENT IN VIVOThe Journal of Experimental Medicine, 1971
- Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidaseJournal of Clinical Investigation, 1970
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970